Cidara Therapeutics Inc (CDTX)
23.43
+0.03
(+0.13%)
USD |
NASDAQ |
Dec 24, 16:00
Cidara Therapeutics Free Cash Flow: -160.15M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biomarin Pharmaceutical Inc | 300.88M |
| Arbutus Biopharma Corp | -71.92M |
| GlycoMimetics Inc | -35.02M |
| FibroGen Inc | -126.23M |
| Cue Biopharma Inc | -38.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.70M |
| Cash from Investing (Quarterly) | -0.106M |
| Cash from Financing (Quarterly) | -0.182M |
| Free Cash Flow Per Share (Quarterly) | -5.636 |
| Free Cash Flow Yield | -135.6% |